First Stage Investor

Startup Insider: 20/20 GeneSystems Pivots, Builds New Partnership

Startup Insider: 20/20 GeneSystems Pivots, Builds New Partnership
By Early Investing
Date September 19, 2022
Share
20/20 GeneSystems has been busy. We first recommended the company in December 2017 when we learned about its incredible cancer detection technology. 20/20 GeneSystems identifies cancer risk early on by using tumor antigen markers. It can improve cancer detection by up to 30%…
Early Investing

First Stage Investor

Sign up to view this First Stage Investor article

Become a smarter investor! Discover new investment opportunities and get the latest market research, trends and analysis in startups, crypto and cannabis.

Top Posts on Early Investing